CARDIOVASCULAR  RESEARCH, RE-IMAGINED.

Aiming to reduce the burden of cardiovascular disease – the number one cause of mortality in western society.

Sydney Cardiovascular Research Consortium
WHO WE ARE

Sydney CRC

The Sydney Cardiovascular Research Consortium (Sydney CRC) is the largest partnership of cardiovascular researchers in Australia, bringing together enormous resources and expertise in a unified and focused collaboration.

“The overarching vision of the Sydney CRC is to find entirely new and innovative approaches to dramatically reduce the burden of cardiovascular disease on the community.” – Professor Shaun Jackson.

Sydney CRC is comprised of Heart Research Institute (HRI), The University of Sydney (USYD), Charles Perkins Centre (CPC), Royal Prince Alfred Hospital (RPA), Sydney Local Health District (SLHD), and affiliated medical research institutes such as the Centenary Institute and The George Institute for Global Health.

JOIN US: SYDNEY CARDIOVASCULAR FELLOWSHIPS

The Heart Research Institute and the Charles Perkins Centre of the University of Sydney are seeking exceptional national and international early to mid-career researchers with the potential to become global leaders in cardiovascular research for the Sydney Cardiovascular Fellowships.

These fellowships represent the most prestigious fellowships in Australia for cardiovascular researchers and are valued at $1,000,000 over a period of five years. For truly exceptional mid-career or later research leaders, we will negotiate an appropriately attractive package (up to $2,000,000 over five years). The fellowships are open to Australian and international applicants.

 

NEW SOUTH WALES: THE PREMIER STATE FOR CARDIOVASCULAR HEALTH

In 2018, the NSW Government established the Cardiovascular Disease Research Capacity Building Program: a $150 million funding package to support the state’s current world-renowned cardiovascular researchers and future NSW-based researchers.

This innovative program will focus on fast tracking new treatments and prevention strategies, and confirms NSW – the home of Sydney CRC – as the premier state for cardiovascular health in Australia.

 

Press release

OUR RESEARCH PIPELINE

To achieve our mission of dramatically reducing the burden of cardiovascular disease, the Sydney CRC has developed a powerful research pipeline that optimises opportunity for discovery of novel markers, effectors, and predictors of cardiovascular disease, mechanistic interrogation in the laboratory, and the subsequent implementation of findings into clinical practice.

By harnessing well-phenotyped clinical cohorts, robust post-genomic profiling platforms, state-of-the-art laboratories, drug development and biomaterial engineering facilities, and world-renowned expertise in each of these disciplines, we are in a strong position to make significant advances in cardiovascular research.

 

Take a virtual tour of our world class facilities

Advantages of the Sydney CRC approach:

  • A much greater critical mass of cardiovascular research
  • A destination for the most competitive cardiovascular basic biomedical researchers
  • A number of world class research areas through new collaborations established between HRI and Charles Perkins Centre/USyd/SLHD/Sydney Research
  • A destination for world-class education and training

Core activities include:

  • A discovery engine
  • A focus on developing new and innovative therapeutics
  • More effective delivery of healthcare (the golden hour)
  • Development of new coatings and materials (stents, valves, artificial blood vessels etc)
  • Advances in robotics and minimally invasive CV surgery.
  • Post-genomic and metabolomics research.

NEW FELLOWS

We welcome the newest members of the Sydney Cardiovascular Research Consortium, each exploring groundbreaking research into different areas and aspects of cardiovascular disease.

Dr John O’Sullivan – MD PhD FAHA FRCPI

Cardiometabolic Disease Group Leader, Heart Research Institute & The University of Sydney


Dr Anna Waterhouse – PhD BSc (Hons I)

Cardiovascular Medical Devices Group Leader, Heart Research Institute & The University of Sydney

Dr Ashish Misra – BSc M.Tech PhD

Atherosclerosis and Vascular Remodeling Group Leader, Heart Research Institute


Dr Freda Passam – MD PhD FRACP FRCPA

Haematology Research Group Leader, Heart Research Institute & The University of Sydney

SCIENTIFIC LEADERSHIP

Our world-renowned investigators lead research spanning all facets of cardiovascular disease, with particular strength in biomedical and clinical research and trials. Key researchers include the following.

shaun-round2

Professor Shaun Jackson – MBBS (Hons) BMedSci (Hons) PhD

Director of Cardiovascular Research, Heart Research Institute
Charles Perkins Centre

Professor David Celermajer – MBBS MSc PhD DSc FAHA FRACP FAA

Scandrett Professor of Cardiology, The Univeristy of Sydney
Medicine, Central Clinical School
Clinical Director, The Heart Research Institute

Professor Christopher Semsarian – MBBS PhD MPH FRACP FCSANZ FHRS FAHA

Professor of Medicine, Sydney Medical School
Cardiologist, Royal Prince Alfred Hospital, Central Clinical School
Head, Molecular Cardiology Program, Centenary Institute

Professor Stephen Simpson AC BSc MA PhD FAA FRS

Academic Director, Charles Perkins Centre
Professor, School of Life and Environmental Sciences

Professor David James  – FAA

Leonard P. Ullmann Chair of Metabolic Systems Biology, Charles Perkins Centre
Professor, School of Life & Environmental Sciences and Sydney Medical School

Professor Philip Hogg  

Head, ACRF–Centenary Cancer Research Centre
Sydney Catalyst Chair in Translational Cancer Research

OUR PARTNERSHIP INCLUDES

Submit an enquiry

If you have a question about the Sydney Cardiovascular Fellowships, please submit your enquiry through the form on the right, and we will contact you shortly.